Search research articles
Contact Us
Filters
Showing results (41-50 of 129) with videos related to
Page
of 13
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Exacerbation of oxaliplatin neurosensory toxicity following surgery
J-M Gornet, E Savier, F Lokiec, et al.
Cancer
|
April 1, 1980
Small-cell carcinoma of the esophagus: treatment by chemotherapy alone
D P Kelsen, E Weston, R Kurtz, et al.
Neurosurgery
|
April 1, 1979
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinoma
N Sundaresan, D Vugrin, J Nisselbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 24, 1998
Irinotecan-induced immune thrombocytopenia
L Bozec, P Bierling, P Fromont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
P Chollet, M A Bensmaïne, S Brienza, et al.
Archives of Internal Medicine
|
September 1, 1988
Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients
T Le Chevalier, E Cvitkovic, P Caille, et al.
Head & Neck
|
January 1, 1997
Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type
A Fandi, A Taamma, N Azli, et al.
Cancer
|
April 1, 1977
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis
D M Hayes, E Cvitkovic, R B Golbey, et al.
Anti-Cancer Drugs
|
June 5, 2003
Phase I population pharmacokinetics of irofulven
S Urien, J Alexandre, E Raymond, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2002
Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences
M Boisdron-Celle, C Craipeau, S Brienza, et al.
Page
of 13
Search research articles
Search
Showing results (41-50 of 129) with videos related to
Sort By:
Page
of 13
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 16, 2002
Exacerbation of oxaliplatin neurosensory toxicity following surgery
J-M Gornet, E Savier, F Lokiec, et al.
Cancer
|
April 1, 1980
Small-cell carcinoma of the esophagus: treatment by chemotherapy alone
D P Kelsen, E Weston, R Kurtz, et al.
Neurosurgery
|
April 1, 1979
Cerebrospinal fluid markers in central nervous system metastases from testicular carcinoma
N Sundaresan, D Vugrin, J Nisselbaum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 24, 1998
Irinotecan-induced immune thrombocytopenia
L Bozec, P Bierling, P Fromont, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1996
Single agent activity of oxaliplatin in heavily pretreated advanced epithelial ovarian cancer
P Chollet, M A Bensmaïne, S Brienza, et al.
Archives of Internal Medicine
|
September 1, 1988
Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients
T Le Chevalier, E Cvitkovic, P Caille, et al.
Head & Neck
|
January 1, 1997
Palliative treatment with low-dose continuous infusion 5-fluorouracil in recurrent and/or metastatic undifferentiated nasopharyngeal carcinoma type
A Fandi, A Taamma, N Azli, et al.
Cancer
|
April 1, 1977
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis
D M Hayes, E Cvitkovic, R B Golbey, et al.
Anti-Cancer Drugs
|
June 5, 2003
Phase I population pharmacokinetics of irofulven
S Urien, J Alexandre, E Raymond, et al.
Cancer Chemotherapy and Pharmacology
|
April 6, 2002
Influence of oxaliplatin on 5-fluorouracil plasma clearance and clinical consequences
M Boisdron-Celle, C Craipeau, S Brienza, et al.
Page
of 13